Controlled Therapeutics Ltd

Controlled Therapeutics (Scotland) Ltd (CT) is a drug delivery technology company. The company commercializes its polymer drug delivery technology which is capable of providing controlled release of a range of drug molecules over periods up to 24 hours. Its key objective is to develop, manufacture and license pharmaceutical products based on patented drug delivery technologies. The company also conducts research and development. The 3,500 sq. meter building houses the manufacturing facility that has been approved by government agencies to enable its dinoprostone controlled release insert to be manufactured and exported to many markets around the world. CT is a wholly owned subsidiary of Cytokine PharmaSciences Inc. (CPSI). CT together with CPSI are actively interested in research and developing a number of new products. CT is focused on the products that are currently in Phases I through to III. CT is headquartered in East Kilbride, the UK.

Street: 
1 Redwood Place
City: 
East Kilbride
Federal State : 
United Kingdom
WebSite: 
www.ctscotland.com
Fax: 
44-1355-263661

Company Index Score

Current Index Score Historical Index Score
  • Controlled Therapeutics Ltd currently scores 50 % in the index.
  • Controlled Therapeutics Ltd is currently ranked equal 15 out of a total of 35419 included in the NS Company Index. This is the top 0.042 % of all companies.
  • Controlled Therapeutics Ltd is currently ranked 3 out of 8430 companies. This is in the top 0.036 % percent of Healthcare companies ranked in the index.
  • User perception of the company stands at 0 % percent. This differs 50 % percent over the score attributed to the company by other scoring factors.

Latest tweets